Mar 202 minGEN has signed an important partnership and collaboration agreement with Jaguar Health Inc.GEN has signed an important partnership and collaboration agreement with Jaguar Health Inc. As a result of the search for new products,...
Feb 222 minGEN initiates Phase 1 study of the first-in-class investigational drug SUL-238GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara, Türkiye - GEN, a leading specialty pharmaceutical...
Sep 4, 20231 minGEN is on the Fortune 500 Türkiye List!As one of Türkiye's fastest-growing pharmaceutical companies, we are pleased to be included in the Fortune Turkey 500 list. We would like...